New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 28, 2012
07:07 EDTOMEROmeros price target lowered to $16 from $19 at Burrill
Burrill lowered its price target for Omeros after the company announced that OMS103HP did not meet its primary endpoint in patients undergoing arthroscopic partial meniscectomy surgery. The firm notes that OMS103HP achieved statistically significant reduction of postoperative pain, though, and keeps an Outperform rating on the stock.
News For OMER From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 31, 2015
10:14 EDTOMEROmeros slides after blogger predicts 50% downside
Subscribe for More Information
09:33 EDTOMEROmeros mentioned cautiously by Seeking Alpha contributor
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use